Who
Mert Aktar
Director
Company insider
Files Form 4 as: Director, Kyverna Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Oct 2024
- Last trade
- 27 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 29 May 2026 | KYTX Kyverna TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,093 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,582 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,582 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | KYTX Kyverna TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,093 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,351 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | KYTX Kyverna TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,634 at $0.00 | filing |
| 21 Oct 2024filed 24 Oct 2024 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,741 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.